Anti-Emetics for Cancer Chemotherapy???Induced Emesis
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 61 (11) , 1553-1562
- https://doi.org/10.2165/00003495-200161110-00003
Abstract
Currently, the most commonly used routes of administration of antiemetics in chemotherapeutic regimens are oral and intravenous. Patient compliance and thus efficacy of conventional drug schedules...Keywords
This publication has 69 references indexed in Scilit:
- A COMPARISON OF ORAL ONDANSETRON SYRUP OR INTRAVENOUS ONDANSETRON LOADING DOSE REGIMENS GIVEN IN COMBINATION WITH DEXAMETHASONE FOR THE PREVENTION OF NAUSEA AND EMESIS IN PEDIATRIC AND ADOLESCENT PATIENTS RECEIVING MODERATELY/HIGHLY EMETOGENIC CHEMOTHERAPYPediatric Hematology and Oncology, 2000
- Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapyBone Marrow Transplantation, 1999
- Intranasal MetoclopramideDrugs, 1999
- Consensus proposal for 5HT 3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapySupportive Care in Cancer, 1998
- Neuropharmacology of emesis and its relevance to anti-emetic therapySupportive Care in Cancer, 1998
- Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapyOral Oncology, 1997
- Alternative Routes of Drug Administration—Advantages and Disadvantages (Subject Review)Pediatrics, 1997
- Ondansetron Suppository: A Randomised, Double-Blind, Double-Dummy, Parallel-Group Comparison with Oral Ondansetron for the Prevention of Cyclophosphamide Induced Emesis and NauseaOncology, 1997
- Transfersomes, Liposomes and Other Lipid Suspensions on the Skin: Permeation Enhancement, Vesicle Penetration, and Transdermal Drug DeliveryCritical Reviews in Therapeutic Drug Carrier Systems, 1996
- Transdermal Drug Delivery: Useful ParadigmsJournal of Drug Targeting, 1995